Nick Haft
Founder at Delix Therapeutics, Inc.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Nicholas Haft | M | 35 |
Arcos Ventures SPV LLC
Delix Therapeutics, Inc.
Delix Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Delix Therapeutics, Inc. is a clinical-stage neuroscience company that focuses on developing novel neuroplasticity-promoting therapeutics to treat neuropsychiatric and neurological disorders. The company's compounds are small molecules that can induce structural and functional neural changes in targeted areas of the brain. Delix is pioneering a new class of fast-acting outpatient pharmacotherapies and advancing through preclinical and clinical development to bring patients FDA-approved, take-home medicines that will serve several unmet needs. The company is headquartered in Palo Alto, CA, and has subsidiaries in the United States. Delix was founded by David E. Olson, Nick Haft, Nicholas Haft, and Paul A. Conley, and Mark Rus has been the CEO of the company since 2021. | 9 years |
David E. Olson | M | - |
Delix Therapeutics, Inc.
Delix Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Delix Therapeutics, Inc. is a clinical-stage neuroscience company that focuses on developing novel neuroplasticity-promoting therapeutics to treat neuropsychiatric and neurological disorders. The company's compounds are small molecules that can induce structural and functional neural changes in targeted areas of the brain. Delix is pioneering a new class of fast-acting outpatient pharmacotherapies and advancing through preclinical and clinical development to bring patients FDA-approved, take-home medicines that will serve several unmet needs. The company is headquartered in Palo Alto, CA, and has subsidiaries in the United States. Delix was founded by David E. Olson, Nick Haft, Nicholas Haft, and Paul A. Conley, and Mark Rus has been the CEO of the company since 2021. | - |
Paul Conley | M | 56 |
Delix Therapeutics, Inc.
Delix Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Delix Therapeutics, Inc. is a clinical-stage neuroscience company that focuses on developing novel neuroplasticity-promoting therapeutics to treat neuropsychiatric and neurological disorders. The company's compounds are small molecules that can induce structural and functional neural changes in targeted areas of the brain. Delix is pioneering a new class of fast-acting outpatient pharmacotherapies and advancing through preclinical and clinical development to bring patients FDA-approved, take-home medicines that will serve several unmet needs. The company is headquartered in Palo Alto, CA, and has subsidiaries in the United States. Delix was founded by David E. Olson, Nick Haft, Nicholas Haft, and Paul A. Conley, and Mark Rus has been the CEO of the company since 2021.
Omx Ventures LLC
Omx Ventures LLC Investment ManagersFinance OMX Ventures LLC (OMX Ventures) is a venture capital firm founded in 2020. The firm is headquartered in Lincolnshire, Illinois. | 6 years |
Mark Rus | M | - |
Delix Therapeutics, Inc.
Delix Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Delix Therapeutics, Inc. is a clinical-stage neuroscience company that focuses on developing novel neuroplasticity-promoting therapeutics to treat neuropsychiatric and neurological disorders. The company's compounds are small molecules that can induce structural and functional neural changes in targeted areas of the brain. Delix is pioneering a new class of fast-acting outpatient pharmacotherapies and advancing through preclinical and clinical development to bring patients FDA-approved, take-home medicines that will serve several unmet needs. The company is headquartered in Palo Alto, CA, and has subsidiaries in the United States. Delix was founded by David E. Olson, Nick Haft, Nicholas Haft, and Paul A. Conley, and Mark Rus has been the CEO of the company since 2021. | 3 years |
Thomas S. Robertson | M | 81 |
The Wharton School of the University of Pennsylvania
| 17 years |
Frédéric Sweeney | M | - |
Omx Ventures LLC
Omx Ventures LLC Investment ManagersFinance OMX Ventures LLC (OMX Ventures) is a venture capital firm founded in 2020. The firm is headquartered in Lincolnshire, Illinois. | 2 years |
A. Asher | M | - |
Omx Ventures LLC
Omx Ventures LLC Investment ManagersFinance OMX Ventures LLC (OMX Ventures) is a venture capital firm founded in 2020. The firm is headquartered in Lincolnshire, Illinois. | 4 years |
Don N. Kleinmuntz | M | - |
Omx Ventures LLC
Omx Ventures LLC Investment ManagersFinance OMX Ventures LLC (OMX Ventures) is a venture capital firm founded in 2020. The firm is headquartered in Lincolnshire, Illinois. | 3 years |
Vasudev Bailey | M | - |
Delix Therapeutics, Inc.
Delix Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Delix Therapeutics, Inc. is a clinical-stage neuroscience company that focuses on developing novel neuroplasticity-promoting therapeutics to treat neuropsychiatric and neurological disorders. The company's compounds are small molecules that can induce structural and functional neural changes in targeted areas of the brain. Delix is pioneering a new class of fast-acting outpatient pharmacotherapies and advancing through preclinical and clinical development to bring patients FDA-approved, take-home medicines that will serve several unmet needs. The company is headquartered in Palo Alto, CA, and has subsidiaries in the United States. Delix was founded by David E. Olson, Nick Haft, Nicholas Haft, and Paul A. Conley, and Mark Rus has been the CEO of the company since 2021. | 3 years |
Swetha Murali | F | - |
Omx Ventures LLC
Omx Ventures LLC Investment ManagersFinance OMX Ventures LLC (OMX Ventures) is a venture capital firm founded in 2020. The firm is headquartered in Lincolnshire, Illinois. | 3 years |
Jamie Kasuboski | M | - |
Omx Ventures LLC
Omx Ventures LLC Investment ManagersFinance OMX Ventures LLC (OMX Ventures) is a venture capital firm founded in 2020. The firm is headquartered in Lincolnshire, Illinois. | 3 years |
Dan Fero | M | - |
Omx Ventures LLC
Omx Ventures LLC Investment ManagersFinance OMX Ventures LLC (OMX Ventures) is a venture capital firm founded in 2020. The firm is headquartered in Lincolnshire, Illinois. | 4 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Raakhe Kapoor Tandon | F | - |
The Wharton School of the University of Pennsylvania
| 5 years |
Pranav Gupta | M | - |
The Wharton School of the University of Pennsylvania
| 13 years |
William Ogrodnick | M | - |
The Wharton School of the University of Pennsylvania
| 10 years |
Emily Janvey | M | - |
The Wharton School of the University of Pennsylvania
| 5 years |
Eli Simon | M | - |
The Wharton School of the University of Pennsylvania
| 5 years |
Christine Black | F | - |
The Wharton School of the University of Pennsylvania
| 10 years |
Jordan Moelis | M | - |
The Wharton School of the University of Pennsylvania
| 5 years |
David Bard | M | - |
The Wharton School of the University of Pennsylvania
| 12 years |
David Portnoy | M | - |
The Wharton School of the University of Pennsylvania
| 10 years |
Mario Miranda | M | - |
The Wharton School of the University of Pennsylvania
| 11 years |
Jing Lin | F | - |
The Wharton School of the University of Pennsylvania
| 8 years |
Eric Sun | M | - |
The Wharton School of the University of Pennsylvania
| 11 years |
Sapna Tejwani Jethwa | F | - |
The Wharton School of the University of Pennsylvania
| 11 years |
Samir Malik | M | - |
The Wharton School of the University of Pennsylvania
| 7 years |
Justin Green | M | - |
The Wharton School of the University of Pennsylvania
| 11 years |
Rama Sekhar | M | - |
The Wharton School of the University of Pennsylvania
| 2 years |
Steven Finn | M | 38 |
The Wharton School of the University of Pennsylvania
| 4 years |
Jennifer Rowland | F | - |
The Wharton School of the University of Pennsylvania
| 5 years |
Steven Kozhimala | M | - |
The Wharton School of the University of Pennsylvania
| 10 years |
Xiaohan Zhu | M | - |
The Wharton School of the University of Pennsylvania
| 2 years |
Sydney Werber | F | - |
The Wharton School of the University of Pennsylvania
| 4 years |
Robert Hernandez | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
Sandy Lu | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
Jacob Slusser | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
Charles Hauch | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
Jennifer Abrahamsen | F | - |
The Wharton School of the University of Pennsylvania
| 2 years |
Jessica Hatch | F | - |
The Wharton School of the University of Pennsylvania
| 2 years |
Yulia Alekseeva | F | - |
The Wharton School of the University of Pennsylvania
| 2 years |
Evelyn Ni | F | - |
The Wharton School of the University of Pennsylvania
| 2 years |
Matthew Goracy | M | - |
The Wharton School of the University of Pennsylvania
| 2 years |
Robert Wolfman | M | - |
The Wharton School of the University of Pennsylvania
| 2 years |
Ami Naik | F | - |
The Wharton School of the University of Pennsylvania
| 2 years |
Jeanne Chen | F | - |
The Wharton School of the University of Pennsylvania
| 3 years |
Sheetal S. Akole | F | - |
The Wharton School of the University of Pennsylvania
| 4 years |
Ashley Putterman | F | - |
The Wharton School of the University of Pennsylvania
| 4 years |
Patrick Yang | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
Jake Roffman | M | - |
The Wharton School of the University of Pennsylvania
| 2 years |
Sandeep Dudhwewala | M | - |
The Wharton School of the University of Pennsylvania
| 2 years |
Joe Brown | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
Tina Sun | F | - |
The Wharton School of the University of Pennsylvania
| 4 years |
Saket Puri | M | - |
The Wharton School of the University of Pennsylvania
| 2 years |
Rachel Fleszar | F | - |
The Wharton School of the University of Pennsylvania
| 4 years |
Barbara Burtin | F | - |
The Wharton School of the University of Pennsylvania
| 2 years |
David Brooks | M | - |
The Wharton School of the University of Pennsylvania
| 2 years |
Sushaan Modi | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
Benjamin Meyer | M | - |
The Wharton School of the University of Pennsylvania
| 2 years |
Jane Simons | F | - |
The Wharton School of the University of Pennsylvania
| 10 years |
Ran Wei | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
Rebecca Alcalay | F | - |
The Wharton School of the University of Pennsylvania
| 4 years |
Jiten Suthar | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
Vivek V Jois | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
Jack Elgart | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
Adam Levinson | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
Jason Paul Gupta | M | - |
The Wharton School of the University of Pennsylvania
| 2 years |
Michael Pan | M | - |
The Wharton School of the University of Pennsylvania
| 3 years |
Lauren Dickstein | F | - |
The Wharton School of the University of Pennsylvania
| 4 years |
J. Derham | M | 36 |
The Wharton School of the University of Pennsylvania
| 4 years |
Nick A. Smith Wang | M | - |
The Wharton School of the University of Pennsylvania
| 3 years |
Hyunseong Shin | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
Evan Feinberg | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
Leviathan Winn | M | - |
The Wharton School of the University of Pennsylvania
| 2 years |
Abhi Acharya | M | - |
The Wharton School of the University of Pennsylvania
| 2 years |
David Kahane | M | - |
The Wharton School of the University of Pennsylvania
| 2 years |
James Han | M | - |
The Wharton School of the University of Pennsylvania
| 2 years |
Frank Han | M | 40 |
The Wharton School of the University of Pennsylvania
| 2 years |
John A. Urquhart | M | - |
The Wharton School of the University of Pennsylvania
| 2 years |
Anders P. Meyerhoff | M | - |
The Wharton School of the University of Pennsylvania
| 2 years |
Matt McMahon | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
Bradley Aaron Krom | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
Alexander Shashou | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
Albert Kim | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
Wade Evan Henriquez | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
Shilpa Nayyar | F | - |
The Wharton School of the University of Pennsylvania
| 2 years |
Kris Martin | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
Yock Siong Tee | M | - |
The Wharton School of the University of Pennsylvania
| 2 years |
Sharath Reddy | M | - |
The Wharton School of the University of Pennsylvania
| 2 years |
Craig Gottesman | M | - |
The Wharton School of the University of Pennsylvania
| 2 years |
Brandon Einstein | M | - |
The Wharton School of the University of Pennsylvania
| 2 years |
Jackie Bennett Lipkin | F | - |
The Wharton School of the University of Pennsylvania
| 4 years |
Jonathan McEuen | M | - |
The Wharton School of the University of Pennsylvania
| 2 years |
Sean Hong | M | - |
The Wharton School of the University of Pennsylvania
| 6 years |
Benjamin Orthlieb | M | - |
The Wharton School of the University of Pennsylvania
| 2 years |
Haegin Chang | F | - |
The Wharton School of the University of Pennsylvania
| 4 years |
Jue Pu | M | 34 |
The Wharton School of the University of Pennsylvania
| 4 years |
Daniel Williams | M | - |
The Wharton School of the University of Pennsylvania
| 2 years |
Shuchi Rajivshankar Pandya | F | - |
The Wharton School of the University of Pennsylvania
| 2 years |
Hailey Hu | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
Vadnagare Rashmi | F | - |
The Wharton School of the University of Pennsylvania
| 2 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Nick Haft
- Personal Network